Table 2.
Concomitant medications. Angiographic and interventional details
| Current smokers (n = 391) (%) | Non-smokers (n = 695) (%) | p | |
|---|---|---|---|
| Clopidogrel loading dose pre-cathlab | 23.5 | 22.8 | 0.8 |
| Unfractionated heparin pre-cathlab | 70.1 | 71.1 | 0.73 |
| Abciximab pre-cathlab | 65.4 | 67.8 | 0.44 |
| IRA in baseline angiography | |||
| SVG | 0.3 | 0.7 | |
| LMCA | 0.5 | 1 | |
| LAD | 43.2 | 49.8 | |
| LCX | 15 | 10 | |
| RCA | 41 | 38.5 | 0.047 |
| Multi-vessel disease | 45.1 | 54.9 | 0.001 |
| Immediate PCI | 94.9 | 94.4 | 0.72 |
| Thrombectomy usage | 10.7 | 12.2 | 0.46 |
| Stent (total) | 91 | 86.2 | 0.02 |
| Drug-eluting stent | 31.7 | 27.5 | 0.14 |
| Direct stenting | 19.4 | 13.8 | 0.014 |
| IABP | 2.3 | 4.9 | 0.04 |
| No-reflow during PCI | 2.6 | 3.9 | 0.25 |
| Distal embolization during PCI | 1.3 | 2.5 | 0.15 |
| TIMI grade 2–3 flow before PCI | 28.9 | 27.5 | 0.62 |
| TIMI grade 3 flow after PCI | 94.1 | 89.6 | 0.016 |
| STR > 50 % after PCI | 80.6 | 71.8 | 0.001 |
IABP intraaortic balloon pumping, IRA infarct-related artery, LAD left anterior descending artery, LCX left circumflex artery, LMCA left main coronary artery, PCI percutaneous coronary intervention, RCA right coronary artery, STR ST-segment resolution, SVG saphenous vein graft, TIMI thrombolysis in myocardial infarction